Is LXRX a good stock to buy? We came across a bullish thesis on Lexicon Pharmaceuticals, Inc. on BioEquity Watch’s Substack. In this article, we will summarize the bulls’ thesis on LXRX. Lexicon Pharmaceuticals, Inc.’s share was trading at $1.8800 as of June 9th. LXRX’s trailing P/E was 3.74 according to Yahoo Finance.
Pressmaster/Shutterstock.com
Lexicon Pharmaceuticals is a clinical-stage biopharmaceutical company focused on cardiometabolic and neuropathic diseases, anchored by its...
